Last 12 months
Inside the activity.
0 purchase rows · 33 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 1 |
| Dec 2025 | 0 | 2 |
| Jan 2026 | 0 | 2 |
| Feb 2026 | 0 | 4 |
| Mar 2026 | 0 | 5 |
| Apr 2026 | 0 | 2 |
| May 2026 | 0 | 3 |
| Jun 2026 | 0 | 3 |
| Jul 2026 | 0 | 3 |
| Aug 2026 | 0 | 5 |
| Sep 2026 | 0 | 2 |
| Oct 2026 | 0 | 1 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 31, 2024 Filed Jun 4, 2024 21:05 UTC |
Wright Christopher IDirector
|
GrantNon Qualified Stock Option (Right to Buy) · Derivative | 17,492 | $0.00 Strike: $23.40 | $0.00 |
DisclosureSEC source: 0001127602-24-017732 · form4.xml · derivative · entry 8 Wright Christopher I · CIK 0001838503 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,492 Underlying: Ordinary Shares · 17,492 shares Expires 2034-05-31 F9 · derivative.exercise_date: Shares subject to the stock option award vest and become exercisable in full on 5/31/2025. Read SEC document |
| May 31, 2024 Filed Jun 4, 2024 21:05 UTC |
Wright Christopher IDirector
|
GrantRestricted Stock Unit Award · Derivative | 8,013 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-017732 · form4.xml · derivative · entry 7 Wright Christopher I · CIK 0001838503 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,013 Underlying: Ordinary Shares · 8,013 shares Expires not disclosed F4 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one ordinary share. F8 · derivative.exercise_date: Shares subject to the restricted stock unit award vest in full on 5/31/2025. F8 · derivative.expiration_date: Shares subject to the restricted stock unit award vest in full on 5/31/2025. Read SEC document |
| May 31, 2024 Filed Jun 4, 2024 21:01 UTC |
snyderman nancy lynn MDDirector
|
GrantNon Qualified Stock Option (Right to Buy) · Derivative | 17,492 | $0.00 Strike: $23.40 | $0.00 |
DisclosureSEC source: 0001127602-24-017730 · form4.xml · derivative · entry 13 snyderman nancy lynn MD · CIK 0001675198 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,492 Underlying: Ordinary Shares · 17,492 shares Expires 2034-05-31 F7 · derivative.exercise_date: Shares subject to the stock option award vest and become exercisable in full on 5/31/2025. Read SEC document |
| May 31, 2024 Filed Jun 4, 2024 21:01 UTC |
snyderman nancy lynn MDDirector
|
GrantRestricted Stock Unit Award · Derivative | 8,013 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-017730 · form4.xml · derivative · entry 12 snyderman nancy lynn MD · CIK 0001675198 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,013 Underlying: Ordinary Shares · 8,013 shares Expires not disclosed F4 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one ordinary share. F6 · derivative.exercise_date: Shares subject to the restricted stock unit award vest in full on 5/31/2025. F6 · derivative.expiration_date: Shares subject to the restricted stock unit award vest in full on 5/31/2025. Read SEC document |
| May 31, 2024 Filed Jun 4, 2024 20:53 UTC |
GAYNOR RICHARDDirector
|
GrantNon Qualified Stock Option (Right to Buy) · Derivative | 17,492 | $0.00 Strike: $23.40 | $0.00 |
DisclosureSEC source: 0001127602-24-017725 · form4.xml · derivative · entry 10 GAYNOR RICHARD · CIK 0001741284 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,492 Underlying: Ordinary Shares · 17,492 shares Expires 2034-05-31 F7 · derivative.exercise_date: Shares subject to the stock option award vest and become exercisable in full on 5/31/2025. Read SEC document |
| May 31, 2024 Filed Jun 4, 2024 20:53 UTC |
GAYNOR RICHARDDirector
|
GrantRestricted Stock Unit Award · Derivative | 8,013 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-017725 · form4.xml · derivative · entry 9 GAYNOR RICHARD · CIK 0001741284 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,013 Underlying: Ordinary Shares · 8,013 shares Expires not disclosed F4 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one ordinary share. F6 · derivative.exercise_date: Shares subject to the restricted stock unit award vest in full on 5/31/2025. F6 · derivative.expiration_date: Shares subject to the restricted stock unit award vest in full on 5/31/2025. Read SEC document |
| May 31, 2024 Filed Jun 4, 2024 20:51 UTC |
Daglio David Angelo Jr.Director
|
GrantNon Qualified Stock Option (Right to Buy) · Derivative | 17,492 | $0.00 Strike: $23.40 | $0.00 |
DisclosureSEC source: 0001127602-24-017720 · form4.xml · derivative · entry 2 Daglio David Angelo Jr. · CIK 0001837109 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,492 Underlying: Ordinary Shares · 17,492 shares Expires 2034-05-31 F3 · derivative.exercise_date: Shares subject to the stock option award vest and become exercisable in full on 5/31/2025. Read SEC document |
| May 31, 2024 Filed Jun 4, 2024 20:51 UTC |
Daglio David Angelo Jr.Director
|
GrantRestricted Stock Unit Award · Derivative | 8,013 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-017720 · form4.xml · derivative · entry 1 Daglio David Angelo Jr. · CIK 0001837109 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,013 Underlying: Ordinary Shares · 8,013 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one ordinary share. F2 · derivative.exercise_date: Shares subject to the restricted stock unit award vest in full on 5/31/2025. F2 · derivative.expiration_date: Shares subject to the restricted stock unit award vest in full on 5/31/2025. Read SEC document |
| May 31, 2024 Filed Jun 4, 2024 20:49 UTC |
Cooke ShaneDirector
|
GrantNon Qualified Stock Option (Right to Buy) · Derivative | 17,492 | $0.00 Strike: $23.40 | $0.00 |
DisclosureSEC source: 0001127602-24-017716 · form4.xml · derivative · entry 14 Cooke Shane · CIK 0001524823 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,492 Underlying: Ordinary Shares · 17,492 shares Expires 2034-05-31 F7 · derivative.exercise_date: Shares subject to the stock option award vest and become exercisable in full on 5/31/2025. Read SEC document |
| May 31, 2024 Filed Jun 4, 2024 20:49 UTC |
Cooke ShaneDirector
|
GrantRestricted Stock Unit Award · Derivative | 8,013 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-017716 · form4.xml · derivative · entry 13 Cooke Shane · CIK 0001524823 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,013 Underlying: Ordinary Shares · 8,013 shares Expires not disclosed F4 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one ordinary share. F6 · derivative.exercise_date: Shares subject to the restricted stock unit award vest in full on 5/31/2025. F6 · derivative.expiration_date: Shares subject to the restricted stock unit award vest in full on 5/31/2025. Read SEC document |
| April 11, 2024 Filed Apr 12, 2024 20:16 UTC |
Lurker NancyDirector
|
GrantNon Qualified Stock Option (Right to Buy) · Derivative | 22,103 | $0.00 Strike: $24.99 | $0.00 |
DisclosureSEC source: 0001127602-24-012829 · form4.xml · derivative · entry 4 Lurker Nancy · CIK 0001450485 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 22,103 Underlying: Ordinary Shares · 22,103 shares Expires 2034-04-11 F5 · derivative.exercise_date: Shares subject to the stock option award vest in three equal annual installments commencing on 4/11/2025. Read SEC document |
| April 11, 2024 Filed Apr 12, 2024 20:16 UTC |
Lurker NancyDirector
|
GrantRestricted Stock Unit Award · Derivative | 11,255 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-012829 · form4.xml · derivative · entry 3 Lurker Nancy · CIK 0001450485 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,255 Underlying: Ordinary Shares · 11,255 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one ordinary share. F4 · derivative.exercise_date: Shares subject to the restricted stock unit award vest in three equal annual installments commencing on 4/11/2025. F4 · derivative.expiration_date: Shares subject to the restricted stock unit award vest in three equal annual installments commencing on 4/11/2025. Read SEC document |
| April 11, 2024 Filed Apr 12, 2024 20:16 UTC |
Lurker NancyDirector
|
GrantNon Qualified Stock Option (Right to Buy) · Derivative | 4,833 | $0.00 Strike: $24.99 | $0.00 |
DisclosureSEC source: 0001127602-24-012829 · form4.xml · derivative · entry 2 Lurker Nancy · CIK 0001450485 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,833 Underlying: Ordinary Shares · 4,833 shares Expires 2034-04-11 F3 · derivative.exercise_date: Shares subject to the stock option award vest and become exercisable in full on 4/11/2025. Read SEC document |
| April 11, 2024 Filed Apr 12, 2024 20:16 UTC |
Lurker NancyDirector
|
GrantRestricted Stock Unit Award · Derivative | 2,323 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-012829 · form4.xml · derivative · entry 1 Lurker Nancy · CIK 0001450485 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,323 Underlying: Ordinary Shares · 2,323 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one ordinary share. F2 · derivative.exercise_date: Shares subject to the restricted stock unit award vest in full on 4/11/2025. F2 · derivative.expiration_date: Shares subject to the restricted stock unit award vest in full on 4/11/2025. Read SEC document |
| March 18, 2024 Filed Mar 18, 2024 20:02 UTC |
Nichols Christian ToddSVP, Chief Commercial Officer
|
SaleOrdinary Shares | 10,417 | $28.10 | $292,739.58 |
DisclosureSEC source: 0001127602-24-010395 · form4.xml · nonDerivative · entry 1 Nichols Christian Todd · CIK 0001813312 · SVP, Chief Commercial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 65,911 F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 12/14/2023. F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $27.87 to $28.58. Full information regarding the number of shares sold at each separate price can be provided to the issuer, any security holder of the issuer or the SEC staff upon request. Read SEC document |
| February 27, 2024 Filed Feb 27, 2024 21:09 UTC |
Parisi Samuel JosephVP, Finance (Interim PAO)
|
SaleOrdinary Shares | 2,559 | $29.65 | $75,874.35 |
DisclosureSEC source: 0001127602-24-007153 · form4.xml · nonDerivative · entry 3 Parisi Samuel Joseph · CIK 0002010945 · VP, Finance (Interim PAO) 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,717 Read SEC document |
| February 26, 2024 Filed Feb 27, 2024 21:02 UTC |
POPS RICHARD FDirector · Director and CEO, Alkermes plc
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 274,328 | $0.00 Strike: $30.04 | $0.00 |
DisclosureSEC source: 0001127602-24-007137 · form4.xml · derivative · entry 12 POPS RICHARD F · CIK 0001126490 · Director · Director and CEO, Alkermes plc 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 274,328 Underlying: Ordinary Shares · 274,328 shares Expires 2034-02-26 F8 · derivative.exercise_date: Shares underlying the stock option vest and become exercisable in four equal annual installments commencing on 2/26/2025. Read SEC document |
| February 26, 2024 Filed Feb 27, 2024 21:11 UTC |
Nichols Christian ToddSVP, Chief Commercial Officer
|
GrantRestricted Stock Unit Award · Derivative | 21,638 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-007156 · form4.xml · derivative · entry 5 Nichols Christian Todd · CIK 0001813312 · SVP, Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 21,638 Underlying: Ordinary Shares · 21,638 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one ordinary share. F4 · derivative.exercise_date: Shares subject to the restricted stock unit award vest in four equal annual installments, commencing on 2/26/2025. F4 · derivative.expiration_date: Shares subject to the restricted stock unit award vest in four equal annual installments, commencing on 2/26/2025. Read SEC document |
| February 26, 2024 Filed Feb 27, 2024 21:11 UTC |
Nichols Christian ToddSVP, Chief Commercial Officer
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 87,602 | $0.00 Strike: $30.04 | $0.00 |
DisclosureSEC source: 0001127602-24-007156 · form4.xml · derivative · entry 4 Nichols Christian Todd · CIK 0001813312 · SVP, Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 87,602 Underlying: Ordinary Shares · 87,602 shares Expires 2034-02-26 F3 · derivative.exercise_date: Shares underlying the stock option vest and become exercisable in four equal annual installments commencing on 2/26/2025. Read SEC document |
| February 26, 2024 Filed Feb 27, 2024 21:09 UTC |
Parisi Samuel JosephVP, Finance (Interim PAO)
|
GrantRestricted Stock Unit Award · Derivative | 10,986 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-007153 · form4.xml · derivative · entry 6 Parisi Samuel Joseph · CIK 0002010945 · VP, Finance (Interim PAO) 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,986 Underlying: Ordinary Shares · 10,986 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one ordinary share. F4 · derivative.exercise_date: Shares subject to the restricted stock unit award vest in four equal annual installments, commencing on 2/26/2025. F4 · derivative.expiration_date: Shares subject to the restricted stock unit award vest in four equal annual installments, commencing on 2/26/2025. Read SEC document |
| February 26, 2024 Filed Feb 27, 2024 21:09 UTC |
Parisi Samuel JosephVP, Finance (Interim PAO)
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 20,890 | $0.00 Strike: $30.04 | $0.00 |
DisclosureSEC source: 0001127602-24-007153 · form4.xml · derivative · entry 5 Parisi Samuel Joseph · CIK 0002010945 · VP, Finance (Interim PAO) 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,890 Underlying: Ordinary Shares · 20,890 shares Expires 2034-02-26 F3 · derivative.exercise_date: Shares underlying the stock option vest and become exercisable in four equal annual installments commencing on 2/26/2025. Read SEC document |
| February 26, 2024 Filed Feb 27, 2024 21:08 UTC |
Brown Iain MichaelSVP, Chief Financial Officer
|
GrantRestricted Stock Unit Award · Derivative | 22,471 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-007149 · form4.xml · derivative · entry 5 Brown Iain Michael · CIK 0001643456 · SVP, Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 22,471 Underlying: Ordinary Shares · 22,471 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one ordinary share. F4 · derivative.exercise_date: Shares subject to the restricted stock unit award vest in four equal annual installments, commencing on 2/26/2025. F4 · derivative.expiration_date: Shares subject to the restricted stock unit award vest in four equal annual installments, commencing on 2/26/2025. Read SEC document |
| February 26, 2024 Filed Feb 27, 2024 21:08 UTC |
Brown Iain MichaelSVP, Chief Financial Officer
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 90,971 | $0.00 Strike: $30.04 | $0.00 |
DisclosureSEC source: 0001127602-24-007149 · form4.xml · derivative · entry 4 Brown Iain Michael · CIK 0001643456 · SVP, Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 90,971 Underlying: Ordinary Shares · 90,971 shares Expires 2034-02-26 F3 · derivative.exercise_date: Shares underlying the stock option vest and become exercisable in four equal annual installments commencing on 2/26/2025. Read SEC document |
| February 26, 2024 Filed Feb 27, 2024 21:07 UTC |
Gaffin David JosephEVP, CLO, Alkermes, Inc.
|
GrantRestricted Stock Unit Award · Derivative | 27,464 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-007146 · form4.xml · derivative · entry 5 Gaffin David Joseph · CIK 0001675905 · EVP, CLO, Alkermes, Inc. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 27,464 Underlying: Ordinary Shares · 27,464 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one ordinary share. F4 · derivative.exercise_date: Shares subject to the restricted stock unit award vest in four equal annual installments, commencing on 2/26/2025. F4 · derivative.expiration_date: Shares subject to the restricted stock unit award vest in four equal annual installments, commencing on 2/26/2025. Read SEC document |
| February 26, 2024 Filed Feb 27, 2024 21:07 UTC |
Gaffin David JosephEVP, CLO, Alkermes, Inc.
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 111,186 | $0.00 Strike: $30.04 | $0.00 |
DisclosureSEC source: 0001127602-24-007146 · form4.xml · derivative · entry 4 Gaffin David Joseph · CIK 0001675905 · EVP, CLO, Alkermes, Inc. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 111,186 Underlying: Ordinary Shares · 111,186 shares Expires 2034-02-26 F3 · derivative.exercise_date: Shares underlying the stock option vest and become exercisable in four equal annual installments commencing on 2/26/2025. Read SEC document |
| February 26, 2024 Filed Feb 27, 2024 21:04 UTC |
Jackson Blair CurtisEVP, Chief Operating Officer
|
GrantRestricted Stock Unit Award · Derivative | 33,289 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-007139 · form4.xml · derivative · entry 5 Jackson Blair Curtis · CIK 0001842348 · EVP, Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 33,289 Underlying: Ordinary Shares · 33,289 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one ordinary share. F4 · derivative.exercise_date: Shares subject to the restricted stock unit award vest in four equal annual installments, commencing on 2/26/2025. F4 · derivative.expiration_date: Shares subject to the restricted stock unit award vest in four equal annual installments, commencing on 2/26/2025. Read SEC document |
| February 26, 2024 Filed Feb 27, 2024 21:04 UTC |
Jackson Blair CurtisEVP, Chief Operating Officer
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 134,771 | $0.00 Strike: $30.04 | $0.00 |
DisclosureSEC source: 0001127602-24-007139 · form4.xml · derivative · entry 4 Jackson Blair Curtis · CIK 0001842348 · EVP, Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 134,771 Underlying: Ordinary Shares · 134,771 shares Expires 2034-02-26 F3 · derivative.exercise_date: Shares underlying the stock option vest and become exercisable in four equal annual installments commencing on 2/26/2025. Read SEC document |
| February 26, 2024 Filed Feb 27, 2024 21:03 UTC |
Hopkinson Craig C.EVP R&D, Chief Medical Officer
|
GrantRestricted Stock Unit Award · Derivative | 27,464 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-007138 · form4.xml · derivative · entry 5 Hopkinson Craig C. · CIK 0001730048 · EVP R&D, Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 27,464 Underlying: Ordinary Shares · 27,464 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one ordinary share. F4 · derivative.exercise_date: Shares subject to the restricted stock unit award vest in four equal annual installments, commencing on 2/26/2025. F4 · derivative.expiration_date: Shares subject to the restricted stock unit award vest in four equal annual installments, commencing on 2/26/2025. Read SEC document |
| February 26, 2024 Filed Feb 27, 2024 21:03 UTC |
Hopkinson Craig C.EVP R&D, Chief Medical Officer
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 111,186 | $0.00 Strike: $30.04 | $0.00 |
DisclosureSEC source: 0001127602-24-007138 · form4.xml · derivative · entry 4 Hopkinson Craig C. · CIK 0001730048 · EVP R&D, Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 111,186 Underlying: Ordinary Shares · 111,186 shares Expires 2034-02-26 F3 · derivative.exercise_date: Shares underlying the stock option vest and become exercisable in four equal annual installments commencing on 2/26/2025. Read SEC document |
| February 23, 2024 Filed Feb 27, 2024 21:11 UTC |
Nichols Christian ToddSVP, Chief Commercial Officer
|
Exercise / conversionRestricted Stock Unit Award · Derivative | 6,407 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-24-007156 · form4.xml · derivative · entry 3 Nichols Christian Todd · CIK 0001813312 · SVP, Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 19,223 Underlying: Ordinary Shares · 6,407 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one ordinary share. F1 · price: Each restricted stock unit represents a contingent right to receive one ordinary share. F2 · derivative.exercise_date: Shares subject to the restricted stock unit award vest in four equal annual installments, commencing on 2/23/2024. F2 · derivative.expiration_date: Shares subject to the restricted stock unit award vest in four equal annual installments, commencing on 2/23/2024. Read SEC document |
| February 23, 2024 Filed Feb 27, 2024 21:11 UTC |
Nichols Christian ToddSVP, Chief Commercial Officer
|
Tax withholdingOrdinary Shares | 2,845 | $29.57 | $84,126.65 |
DisclosureSEC source: 0001127602-24-007156 · form4.xml · nonDerivative · entry 2 Nichols Christian Todd · CIK 0001813312 · SVP, Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 76,328 Read SEC document |
| February 23, 2024 Filed Feb 27, 2024 21:11 UTC |
Nichols Christian ToddSVP, Chief Commercial Officer
|
Exercise / conversionOrdinary Shares | 6,407 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-24-007156 · form4.xml · nonDerivative · entry 1 Nichols Christian Todd · CIK 0001813312 · SVP, Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 79,173 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one ordinary share. Read SEC document |
| February 23, 2024 Filed Feb 27, 2024 16:06 UTC |
LANDINE MICHAEL JSVP, Corp Dev., Alkermes, Inc.
|
Exercise / conversionRestricted Stock Unit Award · Derivative | 4,077 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-24-007141 · form4.xml · derivative · entry 3 LANDINE MICHAEL J · CIK 0001235600 · SVP, Corp Dev., Alkermes, Inc. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,233 Underlying: Ordinary Shares · 4,077 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one ordinary share. F1 · price: Each restricted stock unit represents a contingent right to receive one ordinary share. F2 · derivative.exercise_date: Shares subject to the restricted stock unit award vest in four equal annual installments, commencing on 2/23/2024. F2 · derivative.expiration_date: Shares subject to the restricted stock unit award vest in four equal annual installments, commencing on 2/23/2024. Read SEC document |
| February 23, 2024 Filed Feb 27, 2024 16:06 UTC |
LANDINE MICHAEL JSVP, Corp Dev., Alkermes, Inc.
|
Tax withholdingOrdinary Shares | 1,811 | $29.57 | $53,551.27 |
DisclosureSEC source: 0001127602-24-007141 · form4.xml · nonDerivative · entry 2 LANDINE MICHAEL J · CIK 0001235600 · SVP, Corp Dev., Alkermes, Inc. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 281,730 Read SEC document |
| February 23, 2024 Filed Feb 27, 2024 16:06 UTC |
LANDINE MICHAEL JSVP, Corp Dev., Alkermes, Inc.
|
Exercise / conversionOrdinary Shares | 4,077 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-24-007141 · form4.xml · nonDerivative · entry 1 LANDINE MICHAEL J · CIK 0001235600 · SVP, Corp Dev., Alkermes, Inc. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 283,541 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one ordinary share. Read SEC document |
| February 23, 2024 Filed Feb 27, 2024 21:09 UTC |
Parisi Samuel JosephVP, Finance (Interim PAO)
|
Exercise / conversionRestricted Stock Unit Award · Derivative | 2,283 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-24-007153 · form4.xml · derivative · entry 4 Parisi Samuel Joseph · CIK 0002010945 · VP, Finance (Interim PAO) 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,851 Underlying: Ordinary Shares · 2,283 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one ordinary share. F1 · price: Each restricted stock unit represents a contingent right to receive one ordinary share. F2 · derivative.exercise_date: Shares subject to the restricted stock unit award vest in four equal annual installments, commencing on 2/23/2024. F2 · derivative.expiration_date: Shares subject to the restricted stock unit award vest in four equal annual installments, commencing on 2/23/2024. Read SEC document |
| February 23, 2024 Filed Feb 27, 2024 21:09 UTC |
Parisi Samuel JosephVP, Finance (Interim PAO)
|
Tax withholdingOrdinary Shares | 672 | $29.57 | $19,871.04 |
DisclosureSEC source: 0001127602-24-007153 · form4.xml · nonDerivative · entry 2 Parisi Samuel Joseph · CIK 0002010945 · VP, Finance (Interim PAO) 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,276 Read SEC document |
| February 23, 2024 Filed Feb 27, 2024 21:09 UTC |
Parisi Samuel JosephVP, Finance (Interim PAO)
|
Exercise / conversionOrdinary Shares | 2,283 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-24-007153 · form4.xml · nonDerivative · entry 1 Parisi Samuel Joseph · CIK 0002010945 · VP, Finance (Interim PAO) 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,948 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one ordinary share. Read SEC document |
| February 23, 2024 Filed Feb 27, 2024 21:08 UTC |
Brown Iain MichaelSVP, Chief Financial Officer
|
Exercise / conversionRestricted Stock Unit Award · Derivative | 5,825 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-24-007149 · form4.xml · derivative · entry 3 Brown Iain Michael · CIK 0001643456 · SVP, Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,475 Underlying: Ordinary Shares · 5,825 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one ordinary share. F1 · price: Each restricted stock unit represents a contingent right to receive one ordinary share. F2 · derivative.exercise_date: Shares subject to the restricted stock unit award vest in four equal annual installments, commencing on 2/23/2024. F2 · derivative.expiration_date: Shares subject to the restricted stock unit award vest in four equal annual installments, commencing on 2/23/2024. Read SEC document |
| February 23, 2024 Filed Feb 27, 2024 21:08 UTC |
Brown Iain MichaelSVP, Chief Financial Officer
|
Tax withholdingOrdinary Shares | 2,587 | $29.57 | $76,497.59 |
DisclosureSEC source: 0001127602-24-007149 · form4.xml · nonDerivative · entry 2 Brown Iain Michael · CIK 0001643456 · SVP, Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 116,344 Read SEC document |
| February 23, 2024 Filed Feb 27, 2024 21:08 UTC |
Brown Iain MichaelSVP, Chief Financial Officer
|
Exercise / conversionOrdinary Shares | 5,825 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-24-007149 · form4.xml · nonDerivative · entry 1 Brown Iain Michael · CIK 0001643456 · SVP, Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 118,931 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one ordinary share. Read SEC document |
| February 23, 2024 Filed Feb 27, 2024 21:07 UTC |
Gaffin David JosephEVP, CLO, Alkermes, Inc.
|
Exercise / conversionRestricted Stock Unit Award · Derivative | 7,689 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-24-007146 · form4.xml · derivative · entry 3 Gaffin David Joseph · CIK 0001675905 · EVP, CLO, Alkermes, Inc. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 23,068 Underlying: Ordinary Shares · 7,689 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one ordinary share. F1 · price: Each restricted stock unit represents a contingent right to receive one ordinary share. F2 · derivative.exercise_date: Shares subject to the restricted stock unit award vest in four equal annual installments, commencing on 2/23/2024. F2 · derivative.expiration_date: Shares subject to the restricted stock unit award vest in four equal annual installments, commencing on 2/23/2024. Read SEC document |
| February 23, 2024 Filed Feb 27, 2024 21:07 UTC |
Gaffin David JosephEVP, CLO, Alkermes, Inc.
|
Tax withholdingOrdinary Shares | 3,414 | $29.57 | $100,951.98 |
DisclosureSEC source: 0001127602-24-007146 · form4.xml · nonDerivative · entry 2 Gaffin David Joseph · CIK 0001675905 · EVP, CLO, Alkermes, Inc. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 164,782 Read SEC document |
| February 23, 2024 Filed Feb 27, 2024 21:07 UTC |
Gaffin David JosephEVP, CLO, Alkermes, Inc.
|
Exercise / conversionOrdinary Shares | 7,689 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-24-007146 · form4.xml · nonDerivative · entry 1 Gaffin David Joseph · CIK 0001675905 · EVP, CLO, Alkermes, Inc. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 168,196 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one ordinary share. Read SEC document |
| February 23, 2024 Filed Feb 27, 2024 21:04 UTC |
Jackson Blair CurtisEVP, Chief Operating Officer
|
Exercise / conversionRestricted Stock Unit Award · Derivative | 8,737 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-24-007139 · form4.xml · derivative · entry 3 Jackson Blair Curtis · CIK 0001842348 · EVP, Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 26,214 Underlying: Ordinary Shares · 8,737 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one ordinary share. F1 · price: Each restricted stock unit represents a contingent right to receive one ordinary share. F2 · derivative.exercise_date: Shares subject to the restricted stock unit award vest in four equal annual installments, commencing on 2/23/2024. F2 · derivative.expiration_date: Shares subject to the restricted stock unit award vest in four equal annual installments, commencing on 2/23/2024. Read SEC document |
| February 23, 2024 Filed Feb 27, 2024 21:04 UTC |
Jackson Blair CurtisEVP, Chief Operating Officer
|
Tax withholdingOrdinary Shares | 3,880 | $29.57 | $114,731.60 |
DisclosureSEC source: 0001127602-24-007139 · form4.xml · nonDerivative · entry 2 Jackson Blair Curtis · CIK 0001842348 · EVP, Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 157,802 Read SEC document |
| February 23, 2024 Filed Feb 27, 2024 21:04 UTC |
Jackson Blair CurtisEVP, Chief Operating Officer
|
Exercise / conversionOrdinary Shares | 8,737 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-24-007139 · form4.xml · nonDerivative · entry 1 Jackson Blair Curtis · CIK 0001842348 · EVP, Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 161,682 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one ordinary share. Read SEC document |
| February 23, 2024 Filed Feb 27, 2024 21:03 UTC |
Hopkinson Craig C.EVP R&D, Chief Medical Officer
|
Exercise / conversionRestricted Stock Unit Award · Derivative | 7,689 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-24-007138 · form4.xml · derivative · entry 3 Hopkinson Craig C. · CIK 0001730048 · EVP R&D, Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 23,068 Underlying: Ordinary Shares · 7,689 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one ordinary share. F1 · price: Each restricted stock unit represents a contingent right to receive one ordinary share. F2 · derivative.exercise_date: Shares subject to the restricted stock unit award vest in four equal annual installments, commencing on 2/23/2024. F2 · derivative.expiration_date: Shares subject to the restricted stock unit award vest in four equal annual installments, commencing on 2/23/2024. Read SEC document |
| February 23, 2024 Filed Feb 27, 2024 21:03 UTC |
Hopkinson Craig C.EVP R&D, Chief Medical Officer
|
Tax withholdingOrdinary Shares | 3,414 | $29.57 | $100,951.98 |
DisclosureSEC source: 0001127602-24-007138 · form4.xml · nonDerivative · entry 2 Hopkinson Craig C. · CIK 0001730048 · EVP R&D, Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 109,709 Read SEC document |
| February 23, 2024 Filed Feb 27, 2024 21:03 UTC |
Hopkinson Craig C.EVP R&D, Chief Medical Officer
|
Exercise / conversionOrdinary Shares | 7,689 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-24-007138 · form4.xml · nonDerivative · entry 1 Hopkinson Craig C. · CIK 0001730048 · EVP R&D, Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 113,123 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one ordinary share. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.